The previous study had reported inhibition of MUC1‐C in hematological malignancies and colon cancer (Ahmad et al., 2017) downregulates TIGAR at the protein level (Yin et al., 2012, 2014). This evidence concerns the gene TIGAR and malignant colon neoplasm.